Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05122676 · ClinicalTrials.gov registry record · NA
More Individualized Care: Assessment and Recovery Through Engagement
A NA study of Depression and Anxiety, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 805
- Enrollment target
- 2
- Study locations
NCT05122676: Active NA study of Depression and Anxiety, sponsored by Kaiser Permanente.
NCT05122676 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 805 participants, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05122676, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 805 participants
- Enrollment target
- 2
- Study locations
Study Summary
The MI-CARE trial tests 12 months of telephone-based nurse care management for patients with depressive symptoms who take or have taken opioids at some time. The study tests whether offering nurse support to the patient and their primary care team that addresses these things and related issues can improve patients' health and well-being. Eligible subjects are identified automatically using health system data and randomly assigned 50:50 to either a no-contact usual care arm or to the arm offered the MI-CARE program.
Primary Outcome
A continuous measure of days of OUD treatment with buprenorphine in the 365 days after randomization from secondary electronic data sources.
Conditions Studied
Interventions
- BEHAVIORAL More Individualized Care: Assessment and Recovery through Engagement (MI-CARE)
Study Locations (2)
Indiana
- Indiana University Health - Indianapolis
Washington
- Kaiser Permanente Washington Health Research Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 805 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What the registry record for NCT05122676 still lists
NCT05122676 is an interventional study that assigns participants to a tested intervention. The registered 805 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target.
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which More Individualized Care: Assessment and Recovery through Engagement (MI-CARE) is the first listed.
NCT05122676 reports a single indexed study location in Indiana, Washington.
Frequently Asked Questions
What is clinical trial NCT05122676 about?
NCT05122676 is a clinical study titled "More Individualized Care: Assessment and Recovery Through Engagement". The MI-CARE trial tests 12 months of telephone-based nurse care management for patients with depressive symptoms who take or have taken opioids at some time. The study tests whether offering nurse support to the patient and their primary care team that addresses these things and related issues can i...
What is the current status of trial NCT05122676?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 805 participants. The study started on 2021-11-10. Estimated completion is 2026-02-28.
What conditions does trial NCT05122676 study?
This clinical trial studies the following conditions: Depression, Anxiety, Opioid-Related Disorders, Pain, Chronic.
What interventions are being tested in trial NCT05122676?
The interventions under investigation include: More Individualized Care: Assessment and Recovery through Engagement (MI-CARE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05122676?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05122676 being conducted?
This trial has 2 study locations across Indiana, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05122676's enrollment target sits among peer trials
805 52nd of 679 higher than 628 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy